Modern Organocopper Chemistry
.pdfModern Organocopper Chemistry. Edited by Norbert Krause
Copyright > 2002 Wiley-VCH Verlag GmbH
ISBNs: 3-527-29773-1 (Hardcover); 3-527-60008-6 (Electronic)
xi
Preface
‘‘When one equivalent of cuprous iodide was treated with one equivalent of methyllithium the yellow, ether-insoluble product was formed. Both the precipitate and the ether solution gave a negative color test with Michler ketone. . . . However, when one equivalent of cuprous iodide was treated with two equivalents of methyllithium a clear, practically colorless ether solution was formed. This ether solution gave a strong color test.’’
H. Gilman, R. G. Jones, L. A. Woods, ‘‘The Preparation of Methylcopper and some Observations on the Decomposition of Organocopper Compounds’’, J. Org. Chem. 1952, 17, 1630–1634.
Fifty years ago, Gilman and coworkers marked the beginning of the era of organocopper reagents as synthetic tools in organic chemistry by describing the first preparation of an organocuprate, namely lithium dimethylcuprate (Me2CuLi LiI). Nonetheless, it took more than a decade after this discovery until the widespread use of organocuprates was initiated by the seminal work of House, Corey and others. Soon, the synthetic versatility of organocopper compounds and in particular those of cuprates (which in the case of the composition R2CuLi LiX are referred to as Gilman reagents) was exploited and, in its wake, created an abundance of new reagents, methods, and applications.
Notable in this respect are the introduction of heterocuprates, the use of ‘‘dummy ligands’’ in order to improve the ‘‘economy’’ of the reagents, the implementation of ‘‘higher-order’’ and ‘‘lower-order’’ cuprates and the development of chiral organocopper reagents. Last but not least, the refinement of both theoretical and experimental methods (e.g., X-ray, NMR spectroscopy, kinetics) has shed light on the structures of organocopper compounds and the mechanism of their reactions. Although nowadays regarded as indispensable tools in the repertoire of synthetic organic chemists, organocopper chemistry is still a vivid field with numerous new copper-promoted transformations and chiral catalysts being developed over the last years.
This book captures recent advances of organocopper chemistry and serves as a detailed guide to the high standard now reached in the field. Brief summaries of previous achievements as well as thorough discussions of new methods and techniques facilitate (even for students) the entry into Modern Organocopper Chemistry, an area that will certainly witness further exciting discoveries in the near future.
xii Preface
Selected authors, all of them being protagonists in the respective area, provide profound expertise about both experimental and theoretical aspects of coppermediated transformations to a wide range of scientists in academia and industry. Combined with essays about structure and mechanism (chapters 1 and 10), Modern Organocopper Chemistry compiles novel techniques for the generation of functionalized organocopper reagents (chapter 2) and heteroatomas well as heteroatomalkylcuprates (chapter 3). Application of these organometallics in reactions with extended multiple bond systems (chapter 4), in reductions (chapter 5) and in stereoselective conjugate addition and substitution reactions (chapters 6–8), as well as their use for the synthesis of biologically active products (chapter 9), round out this monograph
The idea of this book, bringing together all important aspects of Modern Organocopper Chemistry and presenting them in a prolific way, has emerged over the last years in discussions with many colleagues, students and friends. Here, the European Commission deserves special mention for genereous support of several projects within the framework European Cooperation in the Field of Scientific and Technical Research (COST). I thank the authors of this volume for their determination to complete their contribution in time of the 50th anniversary of Gilman’s groundbreaking discovery. Finally, I dedicate this monograph to the over 2000 scientists mentioned in the author index for their original contributions which made the book possible.
Dortmund, December 2001 |
Norbert Krause |
Modern Organocopper Chemistry. Edited by Norbert Krause Copyright > 2002 Wiley-VCH Verlag GmbH ISBNs: 3-527-29773-1 (Hardcover); 3-527-60008-6 (Electronic)
xiii
List of Authors
Leggy A. Arnold
Department of Organic and Molecular
Inorganic Chemistry
Stratingh Institute
University of Groningen
Nijenborgh 4
NL-9747 AG Groningen
The Netherlands
Jan-Erling Ba¨ckvall
Department of Organic Chemistry
Arrhenius Laboratory
Stockholm University
S-10691 Stockholm
Sweden
Bodo Betzemeier
Department Chemie
Ludwig-Maximilians-Universita¨t Mu¨nchen
Butenandtstr. 5–13, Haus F
D-81377 Mu¨nchen
Germany
Bernhard Breit
Institut fu¨r Organische Chemie und Biochemie
Albertstr. 21 D-79104 Freiburg Germany
Yukiyasu Chounan
Department of Natural Science
Faculty of Education
Hirosaki University
Hirosaki 036-8560
Japan
Peter Demel
Institut fu¨r Organische Chemie und Biochemie
Albertstr. 21
D-79104 Freiburg
Germany
R. Karl Dieter
Hunter Laboratory
Department of Chemistry
Clemson University
Clemson, SC 29634-0973
USA
Ben L. Feringa
Department of Organic and Molecular
Inorganic Chemistry
Stratingh Institute
University of Groningen
Nijenborgh 4
NL-9747 AG Groningen
The Netherlands
Anja Ho mann-Ro¨der
Dortmund University
Organic Chemistry II
D-44221 Dortmund
Germany
Rosalinde Imbos
Department of Organic and Molecular
Inorganic Chemistry
Stratingh Institute
University of Groningen
Nijenborgh 4
NL-9747 AG Groningen
The Netherlands
Johann T. B. H. Jastrzebski
Debye Institute
Department of Metal-Mediated Synthesis
Utrecht University
Padualaan 8
NL-3584 CH Utrecht
The Netherlands
xivList of Authors
Sofia E. Karlstro¨m
Department of Organic Chemistry Arrhenius Laboratory
Stockholm University S-10691 Stockholm Sweden
Paul Knochel Department Chemie
Ludwig-Maximilians-Universita¨t Mu¨nchen Butenandtstr. 5–13, Haus F
D-81377 Mu¨nchen Germany
Norbert Krause Organic Chemistry II Dortmund University D-44221 Dortmund Germany
Bruce H. Lipshutz
Department of Chemistry & Biochemistry University of California
Santa Barbara, CA 93106 USA
Seiji Mori
Department of Environmental Sciences Ibaraki University
Mito 310-8512 Japan
Robert Naasz
Department of Organic and Molecular
Inorganic Chemistry
Stratingh Institute
University of Groningen
Nijenborgh 4
NL-9747 AG Groningen
The Netherlands
Eiichi Nakamura
Department of Chemistry
The University of Tokyo
Bunkyo-ku
Tokyo 113-0033
Japan
Gerard van Koten Debye Institute
Department of Metal-Mediated Synthesis Utrecht University
Padualaan 8 NL-3584 CH Utrecht The Netherlands
Yoshinori Yamamoto
Department of Chemistry
Graduate School of Science
Tohoku University
Sendai 980-8578
Japan
Modern Organocopper Chemistry. Edited by Norbert Krause Copyright > 2002 Wiley-VCH Verlag GmbH ISBNs: 3-527-29773-1 (Hardcover); 3-527-60008-6 (Electronic)
369
Subject Index
a
acceptor-substituted dienes |
|
||||
1,4-addition 146 |
|
|
|||
1,6-addition 146 |
|
|
|||
addition, regioselectivity of |
145 |
||||
acceptor-substituted enynes |
|
||||
activation parameters |
158 |
|
|||
1,4-addition |
124, 150, 153 |
|
|||
1,6-addition |
124f, 150 , 160, 316, 321 |
||||
anti-Michael addition |
153 |
|
|||
kinetic measurements |
158 |
|
|||
mechanism |
158f |
|
|
||
NMR spectroscopic investigations 158 |
|||||
rate-determining step |
158 |
|
|||
1,4-reduction |
153 |
|
|
||
1,6-reduction |
153 |
|
|
||
tandem 1,6- and 5,6-addition |
151 |
||||
acceptor-substituted polyenynes |
|
||||
1,8-addition |
159, 316 |
|
|
||
1,10-addition |
159f, 316 |
|
|||
1,12-addition |
159f, 316 |
|
|||
acetylenic ethers |
|
|
|
|
|
polyfunctional |
64 |
|
|
||
acridones |
109 |
|
|
|
|
a-acyloxycuprates |
115 |
|
|
||
a-acylthiocuprates |
115 |
|
|
||
1,4-addition |
53, 124, 188, 289f, 293f, 310, |
||||
315, 330, 338, 340; see also respective |
|||||
substrates and reagents |
|
||||
activation parameters |
321 |
|
|||
active substrate control |
190 |
|
|||
acyclic enones |
242 |
|
|
||
aldol reaction |
225 |
|
|
||
auxiliary-controlled 208 |
|
||||
BF3 activation |
333f |
|
|
||
catalytic |
129, 133 |
|
|
||
catalytic cycle |
233 |
|
|
||
CIDNP |
320 |
|
|
|
|
copper-catalyzed |
130, 224, 228 , 234, |
||||
236 , 239, 242f, 252, 322 |
|
cyclic enones 239 |
|
|
|
|||
2-cyclopentenone |
240f |
|
||||
diastereoselectivity 189 , 198 , 202 , |
||||||
208f, 324 |
|
|
|
|
|
|
directed |
200 |
|
|
|
|
|
enantioselectivity |
2, 32, 127 , 224 , 229 , |
|||||
234, 236 , 239 , 252 , 316f, 322 |
||||||
ESR spectroscopy |
320 |
|
||||
four-centered mechanisms |
318 |
|||||
functionalized organocopper compounds |
||||||
46, 51, 54, 65f, 68 |
|
|
||||
Grignard reagents |
1 |
|
|
|||
kinetic measurements |
320f |
|||||
kinetic isotope e ects |
320, 322f, 335 |
|||||
Lewis acid activation |
190, 199f, 332 |
|||||
mechanism |
38, 233, 315, 318f, 321, 322f, |
|||||
327 |
|
|
|
|
|
|
Me3SiCl acceleration |
333 |
|||||
nickel-catalyzed |
229 |
|
|
|||
NMR spectroscopy |
38, 323 |
|||||
passive substrate control |
190 |
|||||
rate-determining step |
320, 322, 335 |
|||||
rhodium-catalyzed |
227, 255 |
|||||
six-centered mechanisms |
318 |
|||||
solvent e ects |
318 |
|
|
|||
transition states |
324 |
|
|
|||
1,6-addition |
124f, 150 , 160, 316 |
|||||
diastereoselectivity |
158 |
|
||||
kinetic isotope e ects |
158 |
|||||
Lewis acid activation |
153 |
|
||||
mechanism |
158f, 321 |
|
||||
NMR Spectroscopy |
158 |
|
||||
rate-determining step |
158 |
|||||
1,8-addition |
159, 316 |
|
|
|||
1,10-addition |
159f, 316 |
|
|
|||
1,12-addition |
159f, 316 |
|
|
|||
alkenylzirconocenes |
|
|
|
|||
cross-coupling |
73 |
|
|
|
||
a-alkoxyalkenylcuprates |
|
|
||||
1,4-addition |
112 |
|
|
|
370 |
Subject Index |
|
|
|
|
|
|
|
a-alkoxyalkylcuprates |
110f, 114f |
|||||
|
|||||||
|
1,4-addition |
111, 113, 132 |
|
||||
|
cyclic |
111 |
|
|
|
|
|
|
enantiomerically pure |
111 |
|||||
|
isomerization |
111 |
|
|
|||
|
racemization |
111 |
|
|
|
||
|
a-alkoxyalkyllithium reagents |
110 |
|||||
|
aldol reactions |
|
|
|
|
|
|
|
diastereoselectivity |
87 |
|
||||
|
alkenyl cuprate |
91 |
|
|
|
||
|
alkenylcopper compounds |
|
|||||
|
cyclization 67 |
|
|
|
|
||
|
functionalized |
52 |
|
|
|
||
|
alkoxy(alkyl)cuprates |
|
|
|
|||
|
1,4-addition 127 , 226 |
|
|||||
|
chiral 127 , 226 |
|
|
|
|||
|
dynamic ligand exchange |
129 |
|||||
|
enantioselectivity 127 , 226 |
||||||
|
alkylcopper compounds |
|
|
||||
|
b-elimination |
167 |
|
|
|
||
|
7-[(E)-alkylidene]-cephalosporins 108 |
||||||
|
alkynes |
|
|
|
|
|
|
|
carbocupration |
73, 145 |
|
||||
|
germylcupration |
100 |
|
||||
|
hydrozirconation |
71f |
|
||||
|
methylalumination |
54 |
|
||||
|
silylcupration |
82, 93 , 96 |
|
||||
|
stannylalumination 54 |
|
|||||
|
stannylcupration |
82, 91, 93 , 96 , 99f |
|||||
|
silylmagnesiation |
95 |
|
||||
|
alkynyl epoxides |
|
|
|
|
|
|
|
kinetic resolution |
284f |
|
||||
|
alkynylcerium reagent |
214 |
|
||||
|
alkynylcuprate |
53f |
|
|
|
||
|
5-alkynylidene-1,3-dioxan-4-ones 157 |
||||||
|
allenes |
150, 153, 155, 172 |
|
||||
|
chiral |
157f |
|
|
|
|
|
|
functionalized |
152 |
|
|
|||
|
regioselectivity |
99 |
|
|
|||
|
silylcupration |
82, 93, 96, 100 |
|||||
|
stannylcupration |
82, 93, 99 |
|||||
|
sterically encumbered |
152, 156 |
|||||
|
b-allenic esters |
152, 154 |
|
||||
|
allenic amino acids |
157 |
|
||||
|
allenic copper(III) intermediate |
||||||
|
reductive elimination |
158 |
|
||||
|
allenic natural products |
156 |
|
||||
|
allenolate 325 |
|
|
|
|
|
|
|
protonation |
91 |
|
|
|
|
|
|
allenyl amines |
121 |
|
|
|
||
|
allenyl enolate |
150, 154 |
|
||||
|
aldol reactions |
156 |
|
|
|||
|
carbometalation |
151 |
|
|
|||
|
electrophilic trapping |
155 |
|
oxidation |
156 |
|
|
|
protonation |
154f |
|
||
allenylketene acetals |
155f |
|||
allenylphosphine oxide 325 |
||||
allylic substititon |
see SN 2 0 substitution |
|||
allyl thioethers |
|
|
|
|
SN20 substitution |
266 |
|||
allylcuprate |
102 |
|
|
|
allylic A1;3 strain |
85, 193, 196, 198, 213f, 217 |
|||
allylic carbamates |
|
|
||
SN20 substitution |
263f |
|||
allylic sulfides |
|
|
|
|
SN20 substitution |
267 |
|||
allylic sulfoximines |
|
|||
SN20 substitution |
264 |
|||
ambident enolate |
146 |
|||
ambident substrates |
145 |
|||
amido(alkyl)cuprates |
108 |
|||
1,4-addition |
127 |
|
chiral 127
intramolecular allylic rearrangement 129
NMR spectroscopy 127 |
||||
reductive elimination |
109 |
|||
theoretical calculations |
127 |
|||
thermal stability |
|
125 |
|
|
(G)-amijitrienol 92 |
|
|
||
amino acids |
|
|
|
|
non-protenogenic |
107 |
|
||
a-amino acids |
99 |
|
|
|
functionalized |
94 |
|
||
a-amino alcohols |
107 |
|
||
b-amino alcohols |
107 |
|
||
a-aminoalkylcuprates |
80, 109, 115 |
|||
1,2-addition |
117 |
|
|
|
1,4-addition 117 |
|
|||
enantiomerically pure |
121 |
|||
substitution reactions |
118 |
|||
thermal stability |
|
119 |
|
|
a-aminoalkylstannanes |
|
|||
1,4-addition |
115 |
|
|
|
7-aminocephalosporanic acid 300 |
||||
anhydroretinols |
100 |
|
||
annulation |
|
|
|
|
enantioselectivity |
252 |
|||
antiestrogens |
148 |
|
|
( )-aristermycin 110 arylchromium enone complex
planar chiral |
209 |
arylcopper compounds |
|
functionalized 2, 16, 46, 49f |
|
arylcuprates |
|
aggregation |
28 |
molecular weight determination 27 NMR spectroscopy 27
a-arylselenoalkylcuprates 114 |
|
a-arylthiocuprates 115 |
|
aurodox |
100 |
axial chirality 150, 152, 156 |
|
aziridines |
285f, 300, 305, 327 |
desymmetrization 285 |
b
B956 |
303, 305 |
|
|
|
B957 |
303, 305 |
|
|
|
bafilomycin A1 |
293 |
|
|
|
Bartlett pear constituent |
147 |
|
||
benzoquinone monoacetals |
|
|||
1,4-addition |
247 |
|
|
|
desymmetrization 247 |
|
|
||
biaryls |
22 |
|
|
|
atropselective coupling |
202 |
|
||
palladium-catalyzed coupling |
202 |
|||
symmetric |
4, 16, 25 |
|
|
|
BINAP |
176f, 185, 227, 255 |
|
||
BINOL |
230f, 234, 236 , 241 , 282 |
|||
BIPHEMP 176f |
|
|
||
bis(aryl)copper(II) compounds |
4 |
|||
1,2-bis-(diphenylphosphino)ethane (DPPE) |
||||
10, 11, 16, 33 |
|
|
bis-(diphenylphosphine)ferrocene (DPPF) 185 bis-(diphenylphosphino)methane (DPPM)
10, 11 |
|
|
|
bis(mesityl)copper anions 16 |
|||
bislactim ether |
148 |
|
|
boron-zinc exchange |
59f, 228f |
||
a-borylalkylcuprates |
115 |
||
brevetoxin B |
296f |
|
|
bromoallene |
305 |
|
|
bromothiophene |
50 |
|
c
( )-capnellane 84 |
|
|
|
carbocupration |
47, 67, 73, 145, 289, 309, |
||
315f, 323f, 329, 340 |
|
||
four-centered mechanism |
325 |
||
intramolecular 73 |
|
||
mechanism |
325, 327 |
|
|
rate-determination step |
326 |
||
reductive elimination sequence 73 |
|||
trap-and bite-mechanism |
326 |
||
carbolithiation |
329 |
|
|
carbacyclin analogues |
106 |
|
|
CBS reduction |
280 |
|
|
cephalosporin |
108, 299 |
|
|
D3-cephems 299f |
|
|
|
(G)-chiloscyphone 88 |
|
||
chiral amplification |
see non-linear |
||
enantioselectivity |
|
|
|
|
Subject Index |
371 |
|
|
|
|
chiral auxiliary |
202f, 260, 262f, 268, 271 |
||
chirality transfer |
213, 263 |
|
|
axis-to-center 156f |
|||
chlorotetaine |
148 |
|
|
(þ)-compactin |
84 |
|
|
p-complex 38, 112, 121, 150, 158, 160, 198. |
|||
233, 262, 319f, 321, 323, 336, 338 |
|||
conjugate addition |
see 1,4-addition, 1,6- |
addition etc.
conjugate addition and elimination sequence
271 |
|
|
|
|
|
|
|
copper |
|
|
|
|
|
|
|
oxidation states |
3 |
|
|
|
|||
copper arenethiolate |
9, 23f, 31, 124f, 150, |
||||||
154 |
|
|
|
|
|
|
|
chiral |
2, 131, 272, 276 |
|
|||||
copper benzoate |
|
23 |
|
|
|
||
copper boronate |
|
52 |
|
|
|
||
copper enolate |
169, 176f |
|
|
||||
copper hydride |
167, 169, 171 , 176, 179f, |
||||||
181f |
|
|
|
|
|
|
|
chiral |
177 |
|
|
|
|
|
|
powder X-ray di raction 1784 |
|
||||||
transmission electron microscopy |
184 |
||||||
copper(I) salts |
|
|
|
|
|
|
|
transmetalation |
5 |
|
|
|
|||
copper(II) salts |
|
|
|
|
|
||
oxidizing properties |
5 |
|
|
||||
reduction |
4 |
|
|
|
|
|
|
copper(III) intermediate |
4 , 123, 131, 153, |
||||||
262, 270, 319, 323, 328f, 331f, 336 |
|||||||
reductive elimination |
158, 160 |
|
|||||
copper-carbon bond |
|
|
|
||||
kinetic stability of |
7 |
|
|
||||
cortisone |
334 |
|
|
|
|
|
|
(G)-crotanecine 95 |
|
|
|
||||
12-crown-4 34 |
|
|
|
|
|
||
crown ether |
328, 332 |
|
|
||||
(þ)-cucurmene |
84 |
|
|
|
|||
(þ)-a-cuparenone |
84 |
|
|
|
|||
(þ)-b-cuparenone |
84 |
|
|
|
|||
b-cuprio(III) enolate |
323 |
|
|
||||
b-cuprio ketone |
323 |
|
|
|
|||
a-cuprio(I) ketone |
324 |
|
|
||||
cuprates |
|
|
|
|
|
|
|
chiral |
127, 148, 225 |
|
|
||||
in situ regeneration |
154 |
|
|||||
cyanocuprates |
|
26 |
|
|
|
||
aggregation |
|
36 |
|
|
|
||
EXAFS |
36 |
|
|
|
|
|
|
higher-order |
2, 26, 34 , 81, 337f |
|
|||||
lower-order |
34 , 153, 190, 212, 298, 337 |
||||||
molecular weight determinations |
36f |
||||||
NMR spectroscopy |
35f, 81, 337 |
|
372 |
Subject Index |
|
|
|
|
|
|
|
|
cyanocuprates (cont.) |
|
functionalized |
280 |
||||
|
|
|||||||
|
reactivity |
35 |
|
|
preparation |
59f |
||
|
theoretical studies |
337 |
dipeptide isosteres |
305 |
||||
|
XANES |
36 |
|
|
ortho-diphenylphosphinobenzoyl (o-DPPB) |
|||
|
X-ray crystal structure determination 35f, |
group |
201f |
|
||||
81, 337 |
|
|
|
a-dithioalkylcuprates |
||||
|
cyano-Gilman cuprates |
37, 109f, 150, 152, |
1,4 addition |
113 |
||||
157, 162, 190, 194, 196, 209, 217, 294, |
dummy ligand |
124, 167, 335f |
||||||
296, 300, 302, 316, 337 |
dynemicin |
114 |
|
|||||
|
h5-cycloheptadienyliron complexes 63 |
dysidiolide |
298f |
|
||||
|
2,5-cyclohexadienone ethers |
|
|
|
|
|||
|
1,4-addition |
248 |
|
e |
|
|
|
|
|
2,5-cyclohexadienone monoacetals |
eicosanoid |
300f |
|
||||
|
1,4-addition |
248 |
|
elaiophylin |
|
|
|
2-cyclohexenones 243 |
electrophiles |
|
||||
kinetic resolution |
243 |
hard |
155 |
|
||
cyclosporin A |
294 |
|
soft |
155 |
|
|
|
|
|
enediynes |
|
|
|
d |
|
|
stannylcupration |
96, 100 |
||
Davis’ reagent |
193f |
( )-enterolactone 84 |
||||
density functional (DFT) calculations 330f |
enyne acetates |
|
||||
(þ)-14-deoxyisoamijiol 106 |
SN200 substitution |
161f |
||||
deprotonation |
|
|
enyne oxiranes |
|
||
asymmetric |
121 |
|
SN200 substitution |
161 |
||
des-epoxy-rosaramycin 108 |
ephedrine |
128f |
|
|||
Dewar-Chatt-Duncanson (DCD) complex |
(G)-10-epi-elemol 106 |
|||||
321, 325f |
|
|
epi-widdrol |
106 |
|
|
dialkenylchloroboranes |
epoxides |
see oxiranes, vinyloxiranes |
||||
transmetalation |
52 |
EPR spectroscopy |
109 |
a-dialkoxyalkylcopper reagents |
|
ethyl (2E,6Z)-2,6-dodecadienoate 147 |
||||||||
1,4-addition |
112 |
|
|
ethylenic acetals |
|
|
|
|||
4,40-di-t-butylbiphenyl (DTBB) |
47 |
substitution reactions |
269 |
|||||||
3,4-dichlorocyclobutene-1,2-dione 64 |
EXAFS (extended X-ray absorption fine |
|||||||||
Diels-Alder reactions |
162 |
|
structure spectroscopy) |
3, 36, 39, 318 |
||||||
intramolecular |
65, 156, 289 |
|
|
|
|
|
||||
dienyl acetals |
|
|
|
|
f |
|
|
|
|
|
chiral |
161 |
|
|
|
|
Felkin-Anh model |
192 |
|
||
SN20 substitution |
161, 269 |
|
ferrocene thioethers |
278 |
|
|||||
SN200 substitution |
160, 269 |
ferrocene thiolates |
277 |
|
|
|||||
dienylic carbonates |
|
|
|
ferrocenes |
|
|
|
|
||
SN20 substitution |
161 |
|
chiral |
277 |
|
|
|
|||
dienylic carboxylates |
|
|
ferrocenylamines 280f |
|
|
|||||
SN20 substitution |
160f |
|
chiral |
62 |
|
|
|
|||
SN200 substitution |
160f |
|
FK-506 293f |
|
|
|
||||
a-dietyopterol |
95 |
|
|
|
a-fluoroalkenylcuprates |
122f |
||||
(þ)-dihydrocodeinone |
106 |
|
a-fluoroalkylcuprates 122f |
|
||||||
( )-dihydrocodeinone |
106, 291 |
forskolin |
289f |
|
|
|
||||
2,5-dihydrofurans |
157 |
|
( )-frontalin 84 |
|
|
|
||||
(G)-dihydrojasmone |
113 |
|
frontier molecular orbitals |
210f |
||||||
(G)-dihydronepetalactone 104f |
fullerenes |
317 |
|
|
|
|||||
dimethyl dioxirane (DMDO) |
157 |
|
|
|
|
|
||||
diorganozinc reagents 55 |
|
g |
|
|
|
|
||||
chiral |
60f |
|
|
|
|
germylcopper reagents |
|
|
||
SN20 substitution |
62 |
|
1,4-addition 92f |
|
|
|
|
|
Subject Index |
373 |
|
|
|
|
germylcuprates |
|
k |
|
1,4-addition 92f |
kinetic isotope e ects 130, 158, 317, 320, |
||
SN2 substitution |
106f |
322f, 331, 335 |
|
SN20 substitution 106f |
Kocienski rearrangement 306 |
||
Gilman cuprates |
1, 26, 109, 145, 147, 152f, |
|
|
167, 259, 295, 316, 337 |
l |
||
gold(III) chloride |
157 |
b-lactams 295f, 299 |
|
Grignard reagents |
|
lactones |
functionalized 47 |
|
1,4-addition 250 |
|
Grubb’s catalyst |
253 |
|
(þ)-lanostenol 106 |
|
|
|
leaving group |
h |
|
|
chiral 218, 262 |
Hajos-Parrish annulation |
252 |
[5-13C]-leucine 208 |
|
halogen-magnesium exchange 47 , 58 |
ligand-accelerated catalysis 227, 230 , 283 |
||
Heck reactions |
95 |
|
localized molecular orbitals (LMOs) 326 |
a-heteroarylcuprates 112 |
|
logarithmic reactivity profiles 126f |
|
a-heteroarylzinc cuprates |
114 |
lower order cuprates 337 |
|
heteroatomalkylcuprates |
|
|
|
1,4-addition |
127 |
|
m |
chiral 127 |
|
|
magnesium cuprates |
non-transferable ligands |
123 |
X-ray crystal structure determination 30 |
|||||||||||
a-heteroatomalkylcuprates |
79f, 109f, 114, |
(þ)-magydardiendiol |
84 |
|
|||||||||
121, 123, 134 |
|
|
|
( )-malyngolide 84 |
|
|
|||||||
non-transferable ligands |
123, 126 |
manoalide |
|
306f |
|
|
|
||||||
heteroatomcuprates |
79f, 102, 134 |
mesitylcopper |
12, 16, 23f, 33 |
||||||||||
chiral |
129 |
|
|
|
|
|
metalate rearrangements |
108, 289, 306f |
|||||
hexamethyldisilazidocuprates |
126 |
( )-methylenolactocin 57f |
|||||||||||
higher order cuprates30, 81, 153, 211f, 306 |
( )-N-methylephedrine 278 |
||||||||||||
cryoscopy 337 |
|
|
|
methyl epijasmonate |
57f |
|
|||||||
NMR spectroscopy |
337 |
|
|
7a-methylestrone 148 |
|
||||||||
Horner-Wadsworth-Emmons (HWE) |
(3S, 4S)-4-methyl-3-heptanol 300f |
||||||||||||
olefination |
|
202 |
|
|
|
methyl 2,4,5-tetradecatrienoate 156 |
|||||||
HSAB principle |
|
145, 155, 158, 229 |
(þ)-mevinolin 84 |
see 1,4-addition, 1,6-addition |
|||||||||
hydrido cuprates |
167f |
|
|
Michael addition |
|||||||||
in situ generation |
172 |
|
|
etc. |
|
|
|
|
|
|
|||
1,4-reduction |
|
172 |
|
|
|
Michael acceptors |
|
|
|
||||
hydroalumination |
53 |
|
|
extended |
146 |
|
|
|
|||||
hydroboration |
228f |
|
|
|
misoprostol |
72 |
|
|
|
||||
hydroboration/boron-zinc exchange 62 |
Mitsunobu reaction |
292f |
|
||||||||||
hydroformylation |
202 |
|
|
molybdenum allyl complexes |
|||||||||
hydrosilylation |
181 |
|
|
|
chiral |
209 |
|
|
|
|
|||
a-hydroxyallenes |
157, 284f |
|
|
(þ)-morphine |
106 |
|
|
||||||
hygrolidin |
293 |
|
|
|
|
|
( )-morphine |
106, 290f |
|
||||
|
|
|
|
|
|
|
Mukaiyama aldol reaction |
178 |
|||||
i |
|
|
|
|
|
|
multiple bond systems |
|
|||||
iminophosphines |
243 |
|
|
extended 145 , 160 |
|
||||||||
iodine-zinc exchange |
59f |
|
|
muscone |
128, 226, 240 |
|
|||||||
3-iodo-2-indolylcopper 48 |
|
|
|
|
|
|
|
|
|
||||
iodouracil |
47 |
|
|
|
|
|
n |
|
|
|
|
|
|
Ireland-Claisen rearrangement |
156 |
natural products |
289 ; see individual names |
||||||||||
iron complexes |
|
|
|
|
|
Nazarov cyclization |
102 |
|
|||||
chiral |
209 |
|
|
|
|
|
( )-neopanocin A |
110 |
|
||||
iso[7]-levuglandin D2 |
195, 294f |
nitroalkenes |
|
|
|
|
|
||||||
( )-Isopinocamphenylboran |
61 |
1,4-addition |
196, 224, 250f, 255 |
374Subject Index
3-nitrocoumarins
1,4-addition 251
nonlinear enantioselectivity 128, 131, 234f nontransferable ligands 2, 61, 79f, 108, 123,
126, 134, 167, 224, 272, 335 chiral 224
3-norcephalosporin 172 (G)-norruspoline 119 Nozaki-Hiyama-Kishi reaction 303
o
olivin 193, 195 |
|
|
|
|
|
|
|
|
olivomycin |
193 |
|
|
|
|
|
|
|
organoaluminium reagents |
|
|
|
|||||
transmetalation |
51, 53f |
|
|
|
||||
organoargentates |
27 |
|
|
|
|
|
||
organoaurates |
27, 29, 328 |
|
|
|
||||
organoboron reagents |
|
|
|
|
|
|||
transmetalation |
51 |
|
|
|
|
|||
organocopper(I) compounds |
|
|
|
|||||
aggregation |
2f, 7 , 11 , 16 , 25, 37, 225, |
|||||||
316 |
|
|
|
|
|
|
|
|
ate complex |
10 |
|
|
|
|
|
|
|
autocatalytic decomposition |
6 |
|
||||||
bearing acidic hydrogens |
61 |
|
|
|||||
bonding |
6 |
|
|
|
|
|
|
|
bridging groups |
17f, 23 |
|
|
|
||||
charge disproportionation |
16 |
|
||||||
chiral 29, 61 |
|
|
|
|
|
|
||
cluster structure |
339 |
|
|
|
|
|||
coordinating substituents |
18, 20, 24 |
|||||||
coordination geometries |
6f, 14, 18 |
|||||||
coordination numbers |
6 |
|
|
|
||||
crystallization |
3 |
|
|
|
|
|
||
decomposition |
22, 25 |
|
|
|
||||
degradation |
10 |
|
|
|
|
|
|
|
functionalized |
45 |
|
|
|
|
|||
heteroatom-functionalized |
25, 79 |
|||||||
heteroleptic |
17f, 22f |
|
|
|
|
|||
homoleptic 8, 18 |
|
|
|
|
|
|||
b-hydrogen elimination process |
6, 11 |
|||||||
incorporation of gold |
19 |
|
|
|
||||
incorporation of silver |
19 |
|
|
|||||
in syntheses of organotin halides |
16 |
|||||||
interaggregate exchange |
22 |
|
|
|||||
intermolecular coordination |
14 |
|
||||||
intramolecular coordination |
6, 13 |
|||||||
IR spectroscopy |
3, 39 |
|
|
|
||||
kinetically active species |
37 |
|
|
|||||
Lewis acid-activation |
217 |
|
|
|
||||
molecular orbitals |
7, 80, 210f, 326 |
|||||||
molecular weight determinations |
2, |
|||||||
11 |
|
|
|
|
|
|
|
|
NMR spectroscopy |
3, 9, 22, 39 |
|
non-transferable ligands |
2, 61, 79f, 108, |
||||||
123, 126, 134, 167, 224, 272, 335 |
|
||||||
oxidation |
5 |
|
|
|
|
|
|
oxidative decomposition |
16 |
|
|
||||
protonolysis |
23 |
|
|
|
|
||
reaction with amines |
108 |
|
|
||||
resting-state species |
3 |
|
|
|
|||
self-assembly |
22, 29 |
|
|
|
|||
solubility |
9, 14, 19 |
|
|
|
|
||
stability |
25 |
|
|
|
|
|
|
stabilization |
9f, 13 |
|
|
|
|
||
structure-reactivity relationship |
3, 7, 14, 38f |
||||||
thermal decomposition |
11, 16, 23 |
|
|||||
thermal stability |
9, 6, 9, 18 |
|
|
||||
thermodynamic stability |
18, 22, 37 |
|
|||||
three-center, two-electron bonding 2, 7, 13, |
|||||||
16 |
|
|
|
|
|
|
|
X-ray crystal structure determination |
3 , |
||||||
8f, 11f, 17, 19 , 37 |
|
|
|
||||
organocopper(II) compounds 5 |
|
|
|||||
one-electron reduction process |
4 |
|
|||||
oxidizing properties |
4f |
|
|
|
|||
two-electron reduction process |
4 |
|
|||||
organocuprates |
|
|
|
|
|
|
|
aggregation |
19, 30 |
|
|
|
|
||
anionic |
32 |
|
|
|
|
|
|
bridging groups |
29 |
|
|
|
|
||
chiral 29 |
|
|
|
|
|
|
|
contact ion pairs (CIPs) |
38f |
|
|
||||
p-coordination |
33 |
|
|
|
|
||
disproportionation 32, 37 |
|
|
|||||
enantiomerically pure |
32 |
|
|
||||
heteroleptic |
26f, 31 |
|
|
|
|||
higher order |
30, 81, 153, 211f, 306 , 337 |
||||||
homoleptic |
26f, 32, 37 |
|
|
|
|||
kinetically active species |
32 |
|
|
||||
molecular weight determination |
27 |
|
|||||
neutral |
27 |
|
|
|
|
|
|
NMR spectroscopy |
2, 27, 32, 38 |
|
|||||
non-transferable ligands |
108 |
|
|
||||
orbital interactions |
338 |
|
|
||||
solvens-separated ion pairs (SSIPs) |
38f |
||||||
structure-reactivity relationship |
26 |
|
|||||
thermodynamic stability |
32 |
|
|
||||
X-ray crystal structure determination |
2, |
||||||
26, 29 |
|
|
|
|
|
|
|
organolithium reagents |
|
|
|
|
|||
functionalized |
45 |
|
|
|
|
||
transmetalation |
45 |
|
|
|
|||
organomagnesium reagents |
|
|
|||||
functionalized |
45, 47 |
|
|
|
|||
transmetalation |
45, 47 , 58 |
|
|
||||
organomanganese reagents |
|
|
|||||
1,4-addition |
70f |
|
|
|
|